Explore

Scientists Develop Whole-Body Imaging System to Observe Cellular Communication in Living Animals

Scientists Develop Whole-Body Imaging System to Observe Cellular Communication in Living Animals

Scientists at the Howard Hughes Medical Institute in the U.S. have developed a new whole-body imaging technique, named WHOLISTIC (WHole-Organism Live-Imaging System for recording Tissue and IntraCellular activity), that allows real-time observation of cellular communication across an entire living animal. This advancement bridges the gap between studying individual cells and understanding how an organism functions as a whole. The technique utilizes genetic engineering to make nearly every cell in the body express fluorescent calcium sensors, which light up when calcium levels shift, indicating cellular communication. So far, this method has been successfully applied to transparent animals like larval zebrafish and Danionella cerebrum, capturing cellular activity second by second. This approach has already yielded unexpected findings, such as chondrocytes in fish responding to cold and the brain's protective meninges reacting to ketamine, not just neurons.

New Research Uncovers Dynamic Behavior of Immune Cells in Human Bone Marrow, Impacting Vaccine Longevity and Disease Understanding

New Research Uncovers Dynamic Behavior of Immune Cells in Human Bone Marrow, Impacting Vaccine Longevity and Disease Understanding

Researchers from Georgia Tech and Vanderbilt University have developed a human bone marrow-on-a-chip model, offering an unprecedented view into the behavior of plasma cells, which are crucial for long-term immune memory. Traditionally, these antibody-producing cells were thought to be largely sedentary within the bone marrow. However, the new study, published in Science Advances, reveals that plasma cells exhibit a 'stop-and-go' migration pattern, actively exploring their environment. They were observed to travel through vascular networks and congregate around blood vessels, suggesting these perivascular regions serve as 'safe harbors' for long-term immune memory. This platform allowed scientists to manipulate components of the human bone marrow environment and observe the consequences in real time, challenging previous assumptions about the static nature of these vital immune cells.

Retro Biosciences Adjusts Alzheimer's Drug Dosing in Clinical Trial

Retro Biosciences Adjusts Alzheimer's Drug Dosing in Clinical Trial

Retro Biosciences, a longevity startup backed by Sam Altman, is expanding its Phase 1 safety trial for the Alzheimer's drug RTR-242. The company is adding two new cohorts, increasing total enrollment by over 42% from 76 to 108 participants. This decision comes after initial doses of RTR-242 showed no significant side effects or safety signals. According to Retro CEO Joe Betts-LaCroix, the absence of any signal, even minor side effects, makes it difficult to assess the drug's efficacy at the current dosage. The drug is designed to target lysosomes, which are cellular recycling centers responsible for breaking down old proteins. This process, known as autophagy, tends to slow with age and is linked to neurodegenerative diseases like Alzheimer's and Parkinson's. RTR-242 aims to restore the acidity of aging lysosomes, thereby improving their function. The trial is currently testing the drug in healthy volunteers aged 18 to 65.

NIH-Funded Research Develops Bone Marrow-on-a-Chip Model for Immune Cell Study

NIH-Funded Research Develops Bone Marrow-on-a-Chip Model for Immune Cell Study

Scientists from Georgia Tech and Vanderbilt University, with support from the National Institutes of Health (NIH), have created a novel laboratory model known as a 'bone marrow-on-a-chip.' This advanced platform is designed to observe how antibody-producing plasma cells migrate, mature, and survive within human bone marrow. The model integrates a lymph node-mimicking organoid with a tissue chip that replicates bone marrow conditions. Researchers isolated B cells from human tonsil tissue and blood, growing them in a lymphoid tissue-like environment. Inactivated influenza virus was used to facilitate the transformation of B cells into antibody-secreting plasma cells. Concurrently, a microfluidics-based vascularized microenvironment was developed to mimic the structural and functional aspects of human bone marrow. The final model is assembled within a stack of 96-well plastic plates, featuring multiple channels coated with a gel-like material containing nutrients and growth factors. It replicates both the end...

Texas to Open New Screwworm Fly Production Facility by 2027 Amid Resurgence Concerns

Texas to Open New Screwworm Fly Production Facility by 2027 Amid Resurgence Concerns

The U.S. Department of Agriculture (USDA) is actively combating a resurgence of the New World screwworm, which reappeared in the U.S. in June after decades of absence. The USDA has already released over 1 billion sterile flies to suppress wild populations. To bolster these efforts, a new U.S. plant in Texas is scheduled to commence operations in spring 2027. This facility aims to produce approximately 100 million sterile screwworm flies per week by the end of 2027, with plans to scale up production to 300 million flies per week by the end of 2028. The strategy involves releasing large numbers of sterile male flies to mate with wild females, which typically mate only once, thereby preventing the production of viable offspring and causing the wild population's breeding cycle to collapse. This method has proven effective in past eradication campaigns, including the 1966 U.S. eradication and the 2017 Florida Keys outbreak. Most of the 49 confirmed cases of screwworm by September 9 have been recorded in Texas, ...

Cryopreservation Techniques Advance Plant Genetic Resource Preservation

Cryopreservation Techniques Advance Plant Genetic Resource Preservation

Cryopreservation of plants is a scientific method employed to safeguard plant genetic resources, particularly focusing on medicinal plants. This technique involves storing plant materials such as seeds, embryos, or other tissues at extremely low temperatures to maintain their viability over extended periods. The process is significantly bolstered by advanced biotechnological tools and is a key component of initiatives like CGIAR's Genebanks Accelerator. These efforts aim to improve the accessibility and impact of genetic resources globally through stringent conservation practices, supportive policies, and high-standard phytosanitary controls. Additionally, cryopreservation is frequently integrated with other plant propagation methods, including micropropagation, synthetic seed technology, and in vitro regeneration, to facilitate the rapid multiplication and preservation of diverse plant species. This comprehensive approach ensures the long-term survival and availability of crucial plant genetic material fo...

Ainnocence Inc. Unveils AINN-P1 Protein Model Outperforming Larger AI in Drug Discovery

Ainnocence Inc. Unveils AINN-P1 Protein Model Outperforming Larger AI in Drug Discovery

Ainnocence Inc. Unveils AINN-P1 Protein Model Outperforming Larger AI in Drug Discovery

Cryopreservation Facilities Offer Hope of Revival for Deceased Individuals

Cryopreservation Facilities Offer Hope of Revival for Deceased Individuals

Cryonics facilities are offering individuals the chance to be cryogenically frozen after death, with the hope of future revival. Southern Cryonics, located in Holbrook, New South Wales, is one such facility, housing seven 'patients' suspended in liquid nitrogen at -196C. These individuals paid over $200,000 for the procedure, which involves a vitrification process to prevent cellular damage. The process includes rapidly cooling the body and pumping it with antifreeze-like embalming chemicals to achieve a 'glass-like state.' The facility, one of six worldwide, stores bodies indefinitely until technology for revival is developed. Experts, however, remain skeptical, comparing the process to attempting to restore a defrosted strawberry to its original state. Associate Professor Saffron Bryant, a cryopreservation expert at RMIT University, states that current science does not support the ability to preserve a whole body effectively, citing issues with uneven cooling and the inability to deliver cryoprotectants ...

Johns Hopkins Researchers Develop CloudScope for Continuous Brain Activity Monitoring in Mice

Johns Hopkins Researchers Develop CloudScope for Continuous Brain Activity Monitoring in Mice

Researchers at Johns Hopkins Medicine have developed a new brain imaging approach called CloudScope, which allows for continuous monitoring of brain activity and physiological changes in freely moving mice for over 24 hours. This miniaturized, cloud-based microscope operates autonomously, providing scientists with remote access to live imaging data globally. The technology addresses a long-standing challenge in neuroscience: observing biological processes in the brain that unfold over extended periods. Using CloudScope, the team successfully captured spontaneous seizures in mice that would have been missed by conventional short-term imaging. In brain cancer studies, researchers were able to characterize individual cancer cell behavior and observe dynamic changes in the brain's microenvironment as the disease progressed. This innovation provides a more comprehensive understanding of brain disease progression compared to traditional imaging methods, which typically offer only limited observation windows.

Gilead Sciences Opens New Research Center in California, Expanding Drug Discovery Capabilities

Gilead Sciences Opens New Research Center in California, Expanding Drug Discovery Capabilities

Gilead Sciences Opens New Research Center in California, Expanding Drug Discovery Capabilities

Ainnocence Inc. Unveils AINN-P1, a Protein Foundation Model Outperforming Larger AI Models in Drug Discovery

Ainnocence Inc. Unveils AINN-P1, a Protein Foundation Model Outperforming Larger AI Models in Drug Discovery

Ainnocence Inc. Unveils AINN-P1, a Protein Foundation Model Outperforming Larger AI Models in Drug Discovery

New Transcriptomics Framework Investigates Degenerative Disease Effects on Individual Cells

New Transcriptomics Framework Investigates Degenerative Disease Effects on Individual Cells

Scientists have developed a novel single-cell and spatial transcriptomics framework to precisely investigate damage to individual cells in degenerative diseases. This method, created by researchers at the University of Cologne, University Hospital Cologne, and the Max Planck Institute for Metabolism Research, allows for the detailed analysis of disease progression within individual tissue samples, such as biopsies. The approach utilizes molecular markers, specifically gene expression, to quantify damage to cells. The study, published in the journal Cell Genomics, focused on kidney cells (podocytes) and liver cells (hepatocytes), both of which are crucial in age-related diseases. The computer-assisted method identifies specific marker genes to measure cellular damage and is applicable to both single-cell RNA sequencing data and spatial transcriptome data, making it universally adaptable to various cell types and organs. This framework enables the distinction between early disease mechanisms and later change...